Can't depend, follow & trust IBs. They have their motives & objectives. Provide pos pics to encourage buy If always right, quit job, make $ themselves Why work when can make more $ yourself.
...该集团对长期前景保持谨慎乐观。it is a longer term investment hor.. eg., hold for 2 years ba Thinking of making quick money everyday ...so easy to make quick money meh
No bank failures as predicted by some nuts here. Banks, especially Maybank are doing well. In fact if we include the 30 sen a share dividend investors had just received, Maybank's share price today is almost RM9 a share, the highest in over a year.
1) 2008, bought Maybank @ >4, sold above 7 [Hold for about 2 years, never bought it back] 2) 2020, bought CIMB at an av. price of 3.50 [hold for about 2 years, sold 95% of the holding at an av. price of 5.40)
3) 2023/ 2024, there could be opportunity to buy Public Bank TP of 3
Looking at the tradingview chart you will know what I am saying
Posted by AngTayKor > 2022-12-10 13:17 | Report Abuse Lecanemab causes brain to shrink even faster! ---------- Lecanemab and other drugs that remove amyloid have another side effect that is more mysterious: They seem to cause the brain to shrink.
That concerns scientists including Thambisetty.
"Brain shrinkage represents disease progression," he says. "What is a little worrying to me is that these drugs might be worsening the degenerative process."
Alzheimer's itself causes the brain to shrink, a sign that neurons are dying. So Thambisetty expected Alzheimer's drugs to limit shrinkage, rather than accelerate it.
So did Dr. David Knopman of the Mayo Clinic. "It's moving in the wrong direction," he said during a panel at the Alzheimer's meeting.
Thambisetty wants Eisai to publish detailed information about the changes in brain volume that occurred during its study of lecanemab. --------- Thambisetty is a current FDA Adcom panel member while David Knopman resigned as FDA Adcom panel member in protest due to FDA's Aduhelm accelerated approval fiasco. ------- @DestinyL, rate of brain atrophy is one of the endpoint measurement in lucidity trial. This is the purest form of biomarker in a clinical trial compared to reduction of amyloid deposits. Patients taking HMTM can see slower rate of brain atrophy. ********************************************
Conclusions: These findings reveal the potential for anti-Aβ therapies to compromise long-term brain health by accelerating brain atrophy, and provide new insight into the adverse impact of ARIA.
Bought Maybank at an average price of RM8.30 in early 2020. Received dividends amounting to RM2.13 per share to date. Not many counters would give you such kind of returns.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
1invest1
1,467 posts
Posted by 1invest1 > 2023-04-06 17:57 | Report Abuse
Can't depend, follow & trust IBs.
They have their motives & objectives.
Provide pos pics to encourage buy
If always right, quit job, make $ themselves
Why work when can make more $ yourself.